Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 19, 2026
AMAT vs LRCX: Semiconductor Equipment Stocks Navigating AI-Driven Demand

AMAT vs LRCX: Semiconductor Equipment Stocks Navigating AI-Driven Demand

Key Takeaways

  • Both AMAT and LRCX operate in the semiconductor equipment sector and have delivered substantial year-to-date gains amid strong demand for AI-related chip manufacturing tools.
  • Recent market activity has seen heightened volatility across the sector, with AMAT experiencing notable intraday and weekly declines while LRCX has retreated from earlier all-time highs.
  • AMAT maintains a broader portfolio spanning multiple process technologies, providing diversified exposure compared to LRCX’s more specialized focus on etch and deposition equipment.
  • Analyst sentiment remains constructive for both names, with multiple price target increases reported in recent weeks despite sector-wide pullbacks.
  • Relative performance highlights trade-offs: AMAT has shown resilience in certain segments, while LRCX has benefited from memory and advanced packaging momentum earlier in the year.
  • Market positioning for both stocks continues to hinge on sustained capital expenditure by chipmakers and evolving AI infrastructure requirements.

Why Compare These Two Names

Applied Materials (AMAT) and Lam Research (LRCX) stand out as leading providers of semiconductor manufacturing equipment. The comparison is particularly relevant for investors seeking exposure to the semiconductor supply chain, especially those monitoring AI-driven demand for advanced chips. Growth-oriented portfolios and sector-focused funds often evaluate these names together because of their overlapping customer base and sensitivity to capital spending cycles. This analysis examines recent performance, business characteristics, and market positioning to offer a factual framework for understanding their relative standing.

Applied Materials Overview and Recent Performance

Applied Materials designs and supplies equipment used in the fabrication of semiconductors, display products, and related technologies. The company serves foundry, logic, and memory manufacturers with a diversified product lineup that includes deposition, etch, and inspection tools. In recent weeks, AMAT shares have experienced volatility consistent with broader semiconductor market movements, including a notable decline on July 17 amid sector pressures. Year-to-date returns remain elevated, supported by earlier strong quarterly results that featured record revenue and earnings. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Sentiment has been influenced by ongoing analyst upgrades and raised price targets, reflecting confidence in long-term demand for AI-enabling technologies despite short-term fluctuations.

Lam Research Overview and Recent Performance

Lam Research specializes in equipment for etch, deposition, and clean processes critical to semiconductor production, with particular strength in memory and advanced packaging applications. The company has seen its stock trade near elevated levels earlier in the period before retreating amid recent sector volatility, including a double-digit monthly decline. Earlier gains in 2026 were driven by robust customer spending and positive earnings momentum. Recent market activity reflects similar external factors affecting peers, with analyst commentary continuing to highlight growth potential tied to AI infrastructure while noting near-term variability in share price behavior.

Head-to-Head Comparison

Both companies supply essential tools for semiconductor fabrication, yet differ in portfolio breadth. AMAT offers exposure across a wider array of process steps, potentially reducing concentration risk relative to LRCX’s emphasis on specific deposition and etch technologies. Growth drivers overlap in AI chip demand, though LRCX has historically shown stronger linkage to memory spending cycles. Recent momentum reflects shared sector headwinds, with both names posting substantial prior gains followed by pullbacks. Risk factors include cyclical capital expenditure patterns and geopolitical influences on supply chains. Market sentiment, as reflected in analyst actions, remains supportive for the group, though relative positioning favors consideration of diversification benefits versus specialized exposure.

Exploring AI Trading Bots for Sector Exposure

In my ongoing research, I frequently review Tickeron’s Trending AI Robots page, which curates a selection of high-performing AI trading bots from hundreds available across the platform. These bots trade thousands of different tickers and employ varied strategies, timeframes, and risk parameters. Only those demonstrating strong suitability for prevailing market conditions are featured in the trending section. Performance statistics for available bots typically span wide ranges depending on strategy and market regime, with differences in win rates, drawdowns, and return profiles. All AI trading bots maintain distinct approaches tailored to specific assets and objectives. This resource helps me cross-check ideas generated from fundamental analysis like the one above.

Tickeron AI Verdict

Based on observable factors such as trend consistency across recent market activity, portfolio stability, and positioning within the semiconductor equipment space, Tickeron’s AI may currently assign a modest preference to AMAT. This assessment stems from its broader business diversification, which could support more stable relative performance amid ongoing volatility. The view remains probabilistic and subject to shifts in market conditions, earnings outcomes, or sector dynamics.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMAT, LRCX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AMAT in downward trend: 10-day moving average crossed below 50-day moving average on July 29, 2026

The 10-day moving average for AMAT crossed bearishly below the 50-day moving average on July 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

AMAT moved below its 50-day moving average on July 24, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AMAT entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AMAT's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on AMAT as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AMAT just turned positive on August 06, 2026. Looking at past instances where AMAT's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMAT advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

AMAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (18.215) is normal, around the industry mean (8.640). P/E Ratio (51.566) is within average values for comparable stocks, (168.044). Projected Growth (PEG Ratio) (1.178) is also within normal values, averaging (1.601). Dividend Yield (0.004) settles around the average of (0.006) among similar stocks. P/S Ratio (15.106) is also within normal values, averaging (37.998).

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 65.37B. The market cap for tickers in the group ranges from 555.66K to 689.17B. ASML holds the highest valuation in this group at 689.17B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 6%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 46%. AEHR experienced the highest price growth at 31%, while SMTK experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -53%. For the same stocks of the Industry, the average monthly volume growth was -20% and the average quarterly volume growth was -62%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 33
Price Growth Rating: 45
SMR Rating: 74
Profit Risk Rating: 62
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
AMAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of equipment and software for the semiconductor industries

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
3050 Bowers Avenue
Phone
+1 408 727-5555
Employees
36500
Web
https://www.appliedmaterials.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.